Clincosm LogoSign in Get a demo

Chronic Myeloid Leukemia

Showing 51 - 75 of 224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Feb 22, 2022

Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)

Recruiting
  • Chronic Myeloid Leukemia
  • Pharmaceutical intervention
  • Saint-Étienne, France
    CHU de Saint-Etienne
Feb 24, 2022

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

Completed
  • Chronic Myeloid Leukemia
  • Ascoli Piceno, Italy
  • +21 more
Jan 3, 2022

BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib

Active, not recruiting
  • Chronic Myeloid Leukemia
  • Dasatinib discontinuation
  • Rionero in Vulture, Potenza, Italy
  • +36 more
Jan 4, 2022

Conception/Pregnancy in Adult CML Treated With Tyrosine Kinase

Recruiting
  • Chronic Myeloid Leukemia
  • Pregnancy
    • Rossano, Cosenza, Italy
    • +51 more
    Jan 4, 2022

    TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

    Recruiting
    • Chronic Myeloid Leukemia
    • Pisa, Italy
    • +1 more
    Jan 4, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Adults Trial in Italy (Ponatinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • +2 more
    • Alessandria, Italy
    • +36 more
    Jan 4, 2022

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Chronic Myeloid Leukemia Trial in Italy (Venetoclax, Rituximab)

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • Alessandria, Italy
    • +30 more
    Jan 3, 2022

    Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Omacetaxine mepesuccinate
    • Los Angeles, California
    • +28 more
    Dec 1, 2021

    CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

    Active, not recruiting
    • Chronic Myeloid Leukemia
      • Saint-Pierre, Reunion, France
      • +39 more
      Dec 13, 2021

      Treatment Free Remission, Chronic Myeloid Leukemia Trial in Turin

      Recruiting
      • Treatment Free Remission
      • Chronic Myeloid Leukemia
        • Turin, Italy
          Division of Hematology-AO Mauriziano Hospital, University of Tur
        Nov 17, 2021

        Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

        Completed
        Has Results
        • Chronic Myeloid Leukemia
        • Omacetaxine mepesuccinate
        • Los Angeles, California
        • +31 more
        Nov 11, 2021

        Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

        Terminated
        Has Results
        • Chronic Myeloid Leukemia
        • Omacetaxine mepesuccinate
        • Jacksonville, Florida
        • +9 more
        Nov 6, 2021

        Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)

        Active, not recruiting
        • Chronic Myeloid Leukemia
        • Freiburg, Baden-Württemberg, Germany
        • +14 more
        Nov 4, 2021

        Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)

        Completed
        • Chronic Myeloid Leukemia
        • Stopping treatment with TKI
        • Brno, Czechia
        • +49 more
        Oct 29, 2021

        Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)

        Withdrawn
        • Acute Myeloid Leukemia
        • +7 more
        • MDG1021 dose 1
        • +3 more
        • Leiden, Zuid Holland, Netherlands
          Leiden University Medical Centre
        Sep 30, 2021

        Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Stanford (CD8+ Memory T Cell Infusion, Thiotepa, Fludarabine)

        Suspended
        • Acute Myeloid Leukemia
        • +4 more
        • CD8+ Memory T Cell Infusion
        • +5 more
        • Stanford, California
          Stanford Medical Center
        Sep 23, 2021

        Iclusig PMS in CML or Ph+ALL Patients

        Recruiting
        • Chronic Myeloid Leukemia
        • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
        • Busan, Korea, Republic of
          Kosin University Gaspel Hospital
        Sep 16, 2021

        Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

        Completed
        Has Results
        • Non-Hodgkin's Lymphoma
        • +7 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Sep 14, 2021

        PD-1 and Enhances Killing pH + Leukemia Stem Cells

        Recruiting
        • Chronic Myeloid Leukemia
          • Guangzhou, Guangdong, China
            Department of Hematology,Nanfang Hospital, Southern Medical Univ
          Aug 4, 2021

          Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))

          Completed
          Has Results
          • Acute Myeloid Leukemia
          • +4 more
          • IM-TMI (3Gy)
          • +3 more
          • Chicago, Illinois
            University of Illinois at Chicago
          May 18, 2021

          Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

          No longer available
          • Acute Lymphoblastic Leukemia
          • +11 more
          • CD34+ enriched, T Cell Depleted donor stem cell product
          • San Francisco, California
            University of California, San Francisco
          May 25, 2021